A 24-Week, Phase IIa, Randomized, Double-blind, Placebo-controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA)

By sjmartinez • February 15, 2023

Khanna D, Denton CP, Furst DE, Mayes MD, Matucci-Cerinic M, Smith V, de Vries D, Ford P, Bauer Y, Randall MJ, Ebrahimpoor M, Kupcsik L, Stiers PJ, Deberdt L, Prasad N, Lim S, Pujuguet P, Ahmed S. A 24-Week, Phase IIa, Randomized, Double-blind, Placebo-controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA). Arthritis Rheumatol. 2023 Feb 14. doi: 10.1002/art.42477. Epub ahead of print. PMID: 36787101.

Tags: Publications, Rheumatology

Delayed diagnosis of pemphigus herpetiformis in a patient with dupilumab-associated hypereosinophilia

Smith SE, Swanson LA, Wonnaparhown A, DiCaudo DJ, Nelson SA, Kasperkiewicz M. Delayed diagnosis of pemphigus herpetiformis in a patient with dupilumab-associated hypereosinophilia. JAAD Case[...]

Managing Rosacea with Nanodiamond-zinc Oxide: Real-world Evidence for Reduction in Redness and Acne Lesions

Zhang XD, Bai XS, Teng C, Chilukuri S, Teng J, Ablon G, Gold MH. Managing Rosacea with Nanodiamond-zinc Oxide: Real-world Evidence for Reduction in Redness[...]

COVID-19 Pandemic-Related Disruptions in Routine Cirrhosis Care and Associated Clinical Outcomes among San Francisco Bay Area Veterans

Rubin JB, Loeb R, Monto A, Wong RJ, Cheung R, Batki SL, Ostacher MJ, Shen H, Hoggatt KJ, Satre DD, Khalili M. COVID-19 Pandemic-Related Disruptions[...]